AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimipal M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Tanpal Nutraceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimipal M 1mg/500mg Tablet SR

Diabetic patients with type 2 mellitus may find relief with the anti-diabetic medication Glimipal M 1mg/500mg SR tablets. This dual-action formulation helps manage blood glucose levels. Administer this medication orally with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive treatment plan including dietary modification, exercise, and weight management as directed by your healthcare provider. Lifestyle adjustments are vital for successful diabetes management. Hypoglycemia (low blood sugar) is the most common adverse effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a fast-acting glucose source, like sugary snacks or juice, to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before initiating therapy. Regular blood glucose monitoring is essential, and supplementary blood tests to assess blood cell counts and liver function may be recommended.

Primary Ingredients of Glimipal M 1mg/500mg Tablet SR

No text provided to rephrase.

Uses of Glimipal M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimipal M 1mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimipal M 1mg/500mg Sustained-Release Tablet with food.

Common Side effects of Glimipal M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimipal M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or break it. Consume Glimipal M 1mg/500mg Extended-Release tablets with a meal.

How Glimipal M 1mg/500mg Tablet SR works:

Glimepiride and Metformin 1mg/500mg Extended-Release Tablets (Glimipal M) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimipal M 1mg/500mg SR tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimipal M 1mg/500mg SR tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before taking this drug.

Breast feedingBreast feedingUNSAFE

Extended-release Glimipal M tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glimipal M 1mg/500mg SR tablets, as dose modification may be necessary. Medical advice is recommended. Glimipal M 1mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is prudent during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimipal M 1mg/500mg Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. In patients exhibiting mild to moderate liver disease, initiate treatment with a reduced Glimipal M 1mg/500mg Tablet SR dosage; its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Glimipal M 1mg/500mg Tablet SR :

Should you forget to take a Glimipal M 1mg/500mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimipal M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimipal M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimipal M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimipal M 1mg/500mg Tablet SR and seek immediate medical attention.
Glimipal M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimipal M 1mg/500mg SR Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Long-term use of Glimipal M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To prevent these complications, annual supplemental vitamin B12 is recommended by some researchers.
Glimipal M 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimipal M 1mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimipal M 1mg/500mg Tabl...
62
MRP 75
17% off